Evidence map›Paper›PMID 30087799›Full record

ArticleJournal of pharmacopuncture2017

Anti-

Mohammad Ali Ebrahimzadeh, Mohammad Mohammad Taheri, Ehsan Ahmadpour, Mahbobeh Montazeri, Shahabeddin Sarvi, Mohammad Akbari, Ahmad Daryani

Abstract read
In one paragraph

Article in Journal of pharmacopuncture, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Anti-Interdisciplinary perspectives on infectious diseases · 2022
    Article
  6. Therapeutic Potential and Safety of theFrontiers in cellular and infection microbiology · 2022
    Article
  7. Antimalarial effects of the hydroalcoholic extract ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Article
  8. In vitro and in vivoFood science & nutrition · 2021
    Article
  9. Green Synthesized Silver Nanoparticles UsingIranian journal of pharmaceutical research : IJPR · 2020
    Article
  10. Anti-Advanced biomedical research · 2020
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad Ali EbrahimzadehPharmaceutical Sciences Research Center, School of Pharmacy, Mazandaran University of Medical Sciences Sari, Iran.
Mohammad Mohammad TaheriPharmaceutical Sciences Research Center, School of Pharmacy, Mazandaran University of Medical Sciences Sari, Iran.
Ehsan AhmadpourInfectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mahbobeh MontazeriToxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Shahabeddin SarviToxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Mohammad AkbariToxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Ahmad DaryaniToxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe currently available agents for use against toxoplasmosis have serious limitations. Thus, the aim of the present study was to investigate the anti-

methodsVero cells were treated with different concentrations (from 0 to 400 μg/mL) of the above extracts or with pyrimethamine at a dose of 50 mg/mL (positive control). Then, the viabilities of the

resultsIn the

conclusionThe results of the current study indicate that methanol extract of

Indexed as

Allium paradoxumFeijoa sellowianain vitroin vivoQuercus castaneifoliaToxoplasma gondii

Identifiers

PMID30087799
PMCPMC5633675

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.